As we enter year three of the COVID-19 pandemic, mortality and morbidity has changed.

Robotic surgery is one of the fastest-growing specialties in surgical medicine today.

The first in a series of updates on COVID-19.

The second in a series of updates on COVID-19

The third in a series of updates on COVID-19.

The fourth in a series of updates on COVID-19.

Explore the drivers behind increases in allergy-related diseases.

Investigate the insurance implications of ultrasound tests and fetal health.

Read more about fetal medicine advances and the new opportunities and risks ahead for insurers.

Understand more about who benefits from bariatric surgery and its insurance implications.

Genomic testing is generating important considerations for insurers.

Survey pre-existing condition (PEC) exclusion clause language and governance practices from around the world. 

Evaluate the efficacy of radiosurgery, particularly when used in complex neurological causes. 

Explore Hepatitis C issues, including drug efficacy, verification of medical necessity, and other considerations.

Learn more about robotic surgery's history, current state, and claims considerations. 

Investigate cancer treatment at a time of major medical advances.